Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Condition:   Diffuse Large B Cell Lymphoma Interventions:   Drug: Zanubrutinib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Epirubicin;   Drug: Vincristine;   Drug: Prednisone Sponsor:   Liaoning Tumor Hospital & Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials